186 related articles for article (PubMed ID: 31713447)
1. Co-targeting CK2α and YBX1 suppresses tumor progression by coordinated inhibition of the PI3K/AKT signaling pathway.
Xu WF; Ma YC; Ma HS; Shi L; Mu H; Ou WB; Peng J; Li TT; Qin T; Zhou HM; Fu XQ; Li XH
Cell Cycle; 2019 Dec; 18(24):3472-3490. PubMed ID: 31713447
[TBL] [Abstract][Full Text] [Related]
2. YBX1/lncRNA SBF2-AS1 interaction regulates proliferation and tamoxifen sensitivity via PI3K/AKT/MTOR signaling in breast cancer cells.
Hussain SA; Venkatesh T
Mol Biol Rep; 2023 Apr; 50(4):3413-3428. PubMed ID: 36754932
[TBL] [Abstract][Full Text] [Related]
3. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway.
Shi H; Pu J; Zhou XL; Ning YY; Bai C
Tumour Biol; 2017 May; 39(5):1010428317697568. PubMed ID: 28459375
[TBL] [Abstract][Full Text] [Related]
4. [CK2α Regulates the Metastases and Migration of Lung Adenocarcinoma
A549 Cell Line through PI3K/Akt/GSK-3β Signal Pathway].
Wu A; Li M; Mai Z; Li S; Yang Z
Zhongguo Fei Ai Za Zhi; 2017 Apr; 20(4):233-238. PubMed ID: 28442011
[TBL] [Abstract][Full Text] [Related]
5. Y-box Binding Protein-1 Is Part of a Complex Molecular Network Linking ΔNp63α to the PI3K/akt Pathway in Cutaneous Squamous Cell Carcinoma.
Troiano A; Lomoriello IS; di Martino O; Fusco S; Pollice A; Vivo M; La Mantia G; Calabrò V
J Cell Physiol; 2015 Sep; 230(9):2067-74. PubMed ID: 25639555
[TBL] [Abstract][Full Text] [Related]
6. Stable knockdown of protein kinase CK2-alpha (CK2α) inhibits migration and invasion and induces inactivation of hedgehog signaling pathway in hepatocellular carcinoma Hep G2 cells.
Wu D; Sui C; Meng F; Tian X; Fu L; Li Y; Qi X; Cui H; Liu Y; Jiang Y
Acta Histochem; 2014 Oct; 116(8):1501-8. PubMed ID: 24958341
[TBL] [Abstract][Full Text] [Related]
7. Systemic administration of antisense oligonucleotides simultaneously targeting CK2α and α' subunits reduces orthotopic xenograft prostate tumors in mice.
Trembley JH; Unger GM; Tobolt DK; Korman VL; Wang G; Ahmad KA; Slaton JW; Kren BT; Ahmed K
Mol Cell Biochem; 2011 Oct; 356(1-2):21-35. PubMed ID: 21761204
[TBL] [Abstract][Full Text] [Related]
8. Y-box binding protein-1 promotes tumorigenesis and progression via the epidermal growth factor receptor/AKT pathway in spinal chordoma.
Liang C; Ma Y; Yong L; Yang C; Wang P; Liu X; Zhu B; Zhou H; Liu X; Liu Z
Cancer Sci; 2019 Jan; 110(1):166-179. PubMed ID: 30426615
[TBL] [Abstract][Full Text] [Related]
9. Targeting Phosphorylation of Y-Box-Binding Protein YBX1 by TAS0612 and Everolimus in Overcoming Antiestrogen Resistance.
Shibata T; Watari K; Kawahara A; Sudo T; Hattori S; Murakami Y; Izumi H; Itou J; Toi M; Akiba J; Akagi Y; Tanaka M; Kuwano M; Ono M
Mol Cancer Ther; 2020 Mar; 19(3):882-894. PubMed ID: 31879363
[TBL] [Abstract][Full Text] [Related]
10. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
[TBL] [Abstract][Full Text] [Related]
11. YBX1 regulates tumor growth via CDC25a pathway in human lung adenocarcinoma.
Zhao S; Wang Y; Guo T; Yu W; Li J; Tang Z; Yu Z; Zhao L; Zhang Y; Wang Z; Wang P; Li Y; Li F; Sun Z; Xuan Y; Tang R; Deng WG; Guo W; Gu C
Oncotarget; 2016 Dec; 7(50):82139-82157. PubMed ID: 27384875
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic Y-box binding protein-1 as an effective therapeutic target in drug-resistant cancer.
Kuwano M; Shibata T; Watari K; Ono M
Cancer Sci; 2019 May; 110(5):1536-1543. PubMed ID: 30903644
[TBL] [Abstract][Full Text] [Related]
13. Effects of CK2β subunit down-regulation on Akt signalling in HK-2 renal cells.
Alcaraz E; Vilardell J; Borgo C; Sarró E; Plana M; Marin O; Pinna LA; Bayascas JR; Meseguer A; Salvi M; Itarte E; Ruzzene M
PLoS One; 2020; 15(1):e0227340. PubMed ID: 31910234
[TBL] [Abstract][Full Text] [Related]
14. Casein kinase 2α regulates multidrug resistance-associated protein 1 function via phosphorylation of Thr249.
Stolarczyk EI; Reiling CJ; Pickin KA; Coppage R; Knecht MR; Paumi CM
Mol Pharmacol; 2012 Sep; 82(3):488-99. PubMed ID: 22695718
[TBL] [Abstract][Full Text] [Related]
15. YBX1 Promotes MSC Osteogenic Differentiation by Activating the PI3K/AKT Pathway.
Chen J; Liu Z; Zhang H; Yang Y; Zeng H; Zhong R; Lai S; Liao H
Curr Stem Cell Res Ther; 2023; 18(4):513-521. PubMed ID: 35929633
[TBL] [Abstract][Full Text] [Related]
16. Effect of resveratrol on doxorubicin resistance in breast neoplasm cells by modulating PI3K/Akt signaling pathway.
Chen JM; Bai JY; Yang KX
IUBMB Life; 2018 Jun; 70(6):491-500. PubMed ID: 29637742
[TBL] [Abstract][Full Text] [Related]
17. The versatile role of curcumin in cancer prevention and treatment: A focus on PI3K/AKT pathway.
Hamzehzadeh L; Atkin SL; Majeed M; Butler AE; Sahebkar A
J Cell Physiol; 2018 Oct; 233(10):6530-6537. PubMed ID: 29693253
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker.
Zhao X; Liu Y; Yu S
Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1805-1816. PubMed ID: 28428004
[TBL] [Abstract][Full Text] [Related]
19. Effects of endoplasmic reticulum stress on the autophagy, apoptosis, and chemotherapy resistance of human breast cancer cells by regulating the PI3K/AKT/mTOR signaling pathway.
Zhong JT; Yu J; Wang HJ; Shi Y; Zhao TS; He BX; Qiao B; Feng ZW
Tumour Biol; 2017 May; 39(5):1010428317697562. PubMed ID: 28459209
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase CK2α is overexpressed in classical hodgkin lymphoma, regulates key signaling pathways, PD-L1 and may represent a new target for therapy.
Ruggeri E; Frezzato F; Mouawad N; Pizzi M; Scarmozzino F; Capasso G; Trimarco V; Quotti Tubi L; Cellini A; Cavarretta CA; Ruocco V; Serafin A; Angotzi F; Danesin N; Manni S; Facco M; Piazza F; Trentin L; Visentin A
Front Immunol; 2024; 15():1393485. PubMed ID: 38807597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]